Featured Research

from universities, journals, and other organizations

Folic Acid Lowers Risk Of Cardiovascular Disease

Date:
April 5, 1999
Source:
University Of Michigan
Summary:
University of Michigan scientists have solved the mystery behind folic acid's ability to reduce amounts of a compound called homocysteine, which is associated with an increased risk of heart attacks, strokes and birth defects in humans.

ANN ARBOR---University of Michigan scientists have solved the mystery behind folic acid's ability to reduce amounts of a compound called homocysteine, which is associated with an increased risk of heart attacks, strokes and birth defects in humans.

A team of U-M researchers led by Rowena G. Matthews, Ph.D., and Martha L. Ludwig, Ph.D., discovered the chemical and structural basis for folic acid's effectiveness while conducting research on an enzyme called methylenetetrahydrofolate reductase (MTHFR). This enzyme with the tongue-twisting name catalyzes a critical step in the biochemical chain reaction within cells that converts homocysteine to an essential amino acid called methionine. The U-M study is being published in the April 1 issue of Nature Structural Biology.

"This work illustrates why basic scientific research is so important," said Matthews, the G. Robert Greenberg Distinguished University Professor of Biological Chemistry and chair of the U-M's Biophysics Research Division. "Our original goal was simply to learn more about the biochemistry of MTHFR. We had no prior indication of any specific health-related application for our work, nor did we imagine that this enzyme would prove to be so important for human health.

"Much of the credit should go to the National Institute of General Medical Sciences of the National Institutes of Health," Matthews added, "because they continue to provide funding for this type of untargeted basic research."

Since the 1970s, researchers have known that administration of folic acid dramatically protects against the development of birth defects like spina bifida in humans. More recent evidence has suggested a correlation between high levels of homocysteine in blood and an increased risk of cardiovascular disease or spina bifida. In the mid-1990s, scientists discovered that increased folic acid intake reduced homocysteine. But no one understood how folic acid exerted its effect until the U-M study.

Using X-ray crystallography, Ludwig, Matthews and colleagues were able to picture the molecular structure of MTHFR from the bacterium, E. coli. "We used E. coli as a surrogate for human MTHFR, because there is a high degree of similarity between the two enzymes and human MTHFR is not yet available for biochemical analysis," said Ludwig, a professor of biological chemistry in the U-M Medical School and research biophysicist in the U-M's Biophysics Research Division.

Nestled within the barrel-shaped MTHFR molecule is a vitamin-derived molecule called flavin adenine dinucleotide or FAD. "The critical discovery in our work was that a common mutation in MTHFR promotes the loss of FAD from the enzyme," Matthews said. "If FAD is lost, the enzyme can't do its job. If the enzyme is inactivated, the conversion to methionine cannot take place and homocysteine builds up in blood plasma."

According to Matthews, about 10 percent of people have abnormally high levels of homocysteine, because they inherited a genetic mutation from both parents that alters the DNA specifying their MTHFR enzymes. "Mutated MTHFR is 11 times more susceptible to loss of this essential flavin molecule than the normal enzyme," Matthews said.

"Increased levels of folates help bind FAD more tightly to MTHFR---protecting the enzyme against heat inactivation and allowing the homocysteine-to-methionine conversion pathway to proceed normally," Ludwig said. "Our results suggest that folic acid supplementation will reduce homocysteine levels for normal humans as well as those with the mutant MTHFR."

Collaborators on the U-M study included Brian D. Guenther, postdoctoral fellow, graduate students Christal A. Sheppard from U-M and Pamela Tran from McGill University, and Rima Rozen, a professor at Montreal Children's Hospital and McGill University.

The research was supported by the National Institute of General Medical Sciences of the National Institutes of Health. Rozen received additional funding for this study from the Medical Research Council of Canada.


Story Source:

The above story is based on materials provided by University Of Michigan. Note: Materials may be edited for content and length.


Cite This Page:

University Of Michigan. "Folic Acid Lowers Risk Of Cardiovascular Disease." ScienceDaily. ScienceDaily, 5 April 1999. <www.sciencedaily.com/releases/1999/04/990405065821.htm>.
University Of Michigan. (1999, April 5). Folic Acid Lowers Risk Of Cardiovascular Disease. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/1999/04/990405065821.htm
University Of Michigan. "Folic Acid Lowers Risk Of Cardiovascular Disease." ScienceDaily. www.sciencedaily.com/releases/1999/04/990405065821.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins